trending Market Intelligence /marketintelligence/en/news-insights/trending/i2Z2jhEeTiTYP4h-Ri0hmw2 content esgSubNav
In This List

AnaptysBio prices common stock offering

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


AnaptysBio prices common stock offering

AnaptysBio Inc. priced an underwritten public offering of 3 million common shares at $68.50 apiece for expected gross proceeds of $205.5 million.

The company granted underwriters an option to buy up to an additional 450,000 shares.

The offering is expected to close Oct. 17, subject to customary closing conditions.

Credit Suisse, Jefferies and Stifel are acting as joint book-running managers for the offering, with Wedbush PacGrow, Baird and SunTrust Robinson Humphrey as co-managers.